Description
Tegonat 15 mg contains Tegafur, an oral fluoropyrimidine antineoplastic agent that is converted in the body into 5-fluorouracil (5-FU). It is commonly used as part of combination chemotherapy regimens for multiple solid tumors.
🔬 Mechanism of Action
Tegafur is metabolized into 5-FU, which inhibits the enzyme thymidylate synthase. As a result, it:
- Disrupts DNA synthesis in cancer cells
- Interferes with RNA function
- Leads to cancer cell death, particularly in rapidly dividing cells
💊 Indications
Tegonat 15 mg is indicated for:
- Gastric (stomach) cancer
- Colorectal cancer
- Breast cancer
- Head and neck cancers
- Other solid tumors as prescribed by an oncologist
It is often used in combination with other chemotherapy agents such as uracil or leucovorin.
📌 Key Features
- Strength: 15 mg
- Dosage Form: Oral capsule
- Therapeutic Class: Antimetabolite / Fluoropyrimidine Chemotherapy
- Administration: Taken orally as prescribed, often in combination therapy
- Monitoring: Requires regular blood counts and liver function tests
⚕️ Benefits
- Oral alternative to intravenous 5-FU
- Effective in multiple solid tumors
- Convenient administration for long-term therapy
- Can be combined with other chemotherapy agents for enhanced efficacy
⚠️ Precautions
- Risk of myelosuppression (low blood counts)
- May cause nausea, vomiting, diarrhea, and mucositis
- Liver function abnormalities may occur
- Dose adjustments may be required based on tolerance
- Use strictly under oncologist supervision
Tegonat 15 mg (Tegafur Capsules) provides an effective oral chemotherapy option for various solid tumors, helping inhibit cancer growth and improve treatment outcomes when used under expert medical care.
